To the Editor
We read with interest the article by Cha et al 1 on the comparison among erythrocyte sedimentation rate (ESR) measurement methods. In this article, the authors stated that TEST 1 ESR measurements better reflect the presence of inflammation than do Westergren data in patients with malignancy, autoimmune disease, or infection.
We measured the ESR using the TEST 1 analyzer and Westergren method on samples from 461 patients with rheumatic diseases such as rheumatoid arthritis (RA), systemic lupus erythematosus, and ankylosing spondylitis. There was a good correlation between the results of the 2 methods (correlation coefficient, 0.928), 2 and the average difference of the 2 methods was 2.09. TEST 1 values were higher than the Westergren values, which were opposite the results of Cha et al. 1 Although the ESR is not a specific test for detecting inflammation, it is useful as a diseasemonitoring parameter in patients with RA. 3 We measured the ESR in 287 patients with RA with the TEST 1 and Westergren methods. The 2 methods showed good correlation (y = 0.890x + 5.343; r = 0.963; P < .05). Some authors have suggested that C-reactive protein (CRP) and rheumatoid factor (RF), as well as the ESR, are useful markers in RA, 4,5 so we studied CRP and RF values in patients with RA. Our study revealed that CRP showed a high correlation with ESR, whereas RF showed a low correlation with ESR ❚Table 1❚. Although there was no absolute correlation between ESR and any of the plasma protein fractions, 6 
